Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Medicine at Yale University, discusses overactive bladder treatment with newer drugs such as trospium chloride, and reminds physicians…
NEW YORK (Reuters Health) – New research indicates that tenofovir 300 mg-emtricitabine 200 mg (TDF-FTC) is comparable to abacavir 600 mg-lamivudine 300 mg (ABC-3TC) in anti-HIV efficacy but…
NEW YORK (Reuters Health) – Use of erythropoiesis-stimulating agents in US cancer patients undergoing chemotherapy has increased 10-fold since their introduction, yet there’s been no associated decline in…
NEW YORK (Reuters Health) – Adding angioplasty to medical therapy does not improve the outcomes of patients with renal-artery stenosis and carries substantial risks, according to a report…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…
NEW YORK (Reuters Health) – In patients with locoregionally advanced squamous-cell carcinoma of the head and neck (LASCCHN), the survival benefit of adding cetuximab to radiotherapy is still…
NEW YORK (Reuters Health) – New research suggests that extracorporeal shock-wave therapy (ESWT) is a viable alternative to surgery for long-bone hypertrophic nonunions. “When we examined patients and…
NEW YORK (Reuters Health) – More than half of women in a recent survey had undiagnosed urinary incontinence, with two thirds reporting moderate to severe symptoms. Because urinary…
Hugh S. Taylor, MD, is Professor of Obstetrics, Gynecology and Reproductive Sciences, and Director of Reproductive Endocrinology and Infertility at the Yale University School of Medicine discusses the…
NEW YORK (Reuters Health) – In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival,…
